STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

KNSA KINIKSA PHARMACEUTICALS LIMITED StockScouter® Report

5

StockScouter® Score

KINIKSA PHARMACEUTICALS LIMITED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
  • Moving average analysis for KNSA suggests strong price movement over the medium term. Positive

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • Two or more executives, directors or major shareholders – including one high-level executive –sold a small number of shares recently. Very negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 80% done.
Low
High

Core Model Grades

B
D
C
B

Previous Ratings

5
6
3